Journal
GYNECOLOGICAL ENDOCRINOLOGY
Volume 29, Issue 4, Pages 305-308Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/09513590.2012.743017
Keywords
Adenomyosis; chronic pelvic pain; endometriosis; gonadotropin releasing hormone analogue
Ask authors/readers for more resources
The aim of this study was to evaluate the improvement in catamenial chronic pelvic pain (CPP) after Gonadotropin Releasing Hormone analogue (GnRH-a) administration in women affected by adenomyosis or endometriosis. We retrospectively analysed clinical data of 63 premenopausal women with clinical suspect of adenomyosis (15 women, Group A) or endometriosis (48 women, Group B), which received GnRH-a in order to reduce CPP intensity during the time on surgery waiting list. Main outcome measures were variation of CPP intensity, numbers of days requiring analgesics and lost work productivity before and three months after GnRH-a administration. Compared to baseline, a significant decrease in CPP intensity (p<0.05) was observed in both groups, even if this reduction was significantly higher in Group A than in Group B (p <0.001). In both groups, moreover, a significant reduction in number of days requiring analgesics (p<0.05) and lost work productivity (p<0.05) was detected. In conclusion, GnRH-a administration in women with clinical suspect of adenomyosis induces a greater reduction in CPP when compared to women with endometriosis, thus representing a potential ex adiuvantibus criteria, helping TV-US in the clinical diagnosis of adenomyosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available